OMERS ADMINISTRATION Corp Acquires Shares of 19,815 Stryker Corporation $SYK

Key Points

• OMERS Administration Corp. acquired 19,815 Stryker shares in the second quarter, valued at approximately $6.24 million. Institutional investors collectively own 77.09% of the company.
• Analysts maintain a favorable outlook, with a “Moderate Buy” consensus rating and an average price target of $386.28; targets cited range from $340 to $369.
• Stryker recently exceeded quarterly earnings expectations, reporting $3.69 in EPS and $6.59 billion in revenue, while announcing a quarterly dividend of $0.88 per share, equivalent to a 1.1% annual yield.

OMERS ADMINISTRATION Corp purchased a new position in Stryker Corporation (NYSE:SYK - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 19,815 shares of the medical technology company's stock, valued at approximately $6,239,000.

A number of other large investors also recently bought and sold shares of the business. Brighton Jones LLC grew its stake in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock worth $1,643,000 after buying an additional 609 shares during the last quarter. Schnieders Capital Management LLC. bought a new position in Stryker during the 2nd quarter valued at approximately $205,000. Marshall Wace LLP raised its stake in Stryker by 107.9% during the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company's stock valued at $2,255,000 after buying an additional 77,831 shares during the last quarter. Nebula Research & Development LLC purchased a new position in Stryker during the second quarter valued at $219,000. Finally, HUB Investment Partners LLC bought a new stake in Stryker in the second quarter worth $253,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently commented on SYK. BMO Capital Markets assumed coverage on Stryker in a research note on Wednesday, July 8th. They issued an "outperform" rating and a $369.00 target price on the stock. Evercore set a $350.00 price target on Stryker in a research report on Monday, July 6th. Wall Street Zen upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Truist Financial increased their price objective on shares of Stryker from $330.00 to $340.00 and gave the company a "hold" rating in a research report on Friday, July 31st. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Stryker in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $386.28.

Stryker Stock Down 0.5%

Stryker stock opened at $327.80 on Tuesday. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $396.86. The stock has a fifty day simple moving average of $327.39 and a two-hundred day simple moving average of $332.16. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. The firm has a market cap of $125.73 billion, a price-to-earnings ratio of 33.97, a PEG ratio of 2.10 and a beta of 0.76.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same period in the prior year, the company posted $3.13 earnings per share. The company's quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts predict that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker's dividend payout ratio is currently 36.48%.

Insider Activity

In other news, VP Robert S. Fletcher sold 4,544 shares of the firm's stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president owned 10,582 shares of the company's stock, valued at $3,247,298.34. This trade represents a 30.04% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Debra King sold 826 shares of Stryker stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the sale, the insider owned 6,210 shares of the company's stock, valued at $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 355,370 shares of company stock valued at $119,447,201 in the last 90 days. 4.60% of the stock is currently owned by insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source